Journal of Clinical Oncology

Reply to: Human Leukocyte Antigen Mismatching and the Role of Killer Cell Immunoglobulin-Like Receptor Mismatch in Hematopoietic Cell Transplantation for Hematologic Malignancies

E Esteban Arrieta-Bolanos (3University Hospital Essen, Institute for Experimental Cellular Therapy, Essen, Germany) E Edouard F. Bonneville (Esteban Arrieta-Bolaños, PhD, Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany, German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Germany; Edouard F. Bonneville, MSc, Department of Biomedical Data Sciences, LUMC, Leiden, the Netherlands, EBMT Leiden Study Unit, Leiden, the Netherlands; Annalisa Ruggeri, MD, IRCCS Ospedale San Raffaele, Milan, Italy; and Katharina Fleischhauer, MD, Institute for Experimental Cellular Therapy, University Hospital...) A Annalisa Ruggeri (8San Raffaele Scientific Institute, Milan, Italy) K Katharina Fleischhauer (9Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 6
Published February 20, 2025
Pages 759-760
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (4)

E

Esteban Arrieta-Bolanos

3University Hospital Essen, Institute for Experimental Cellular Therapy, Essen, Germany

E

Edouard F. Bonneville

Esteban Arrieta-Bolaños, PhD, Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany, German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Germany; Edouard F. Bonneville, MSc, Department of Biomedical Data Sciences, LUMC, Leiden, the Netherlands, EBMT Leiden Study Unit, Leiden, the Netherlands; Annalisa Ruggeri, MD, IRCCS Ospedale San Raffaele, Milan, Italy; and Katharina Fleischhauer, MD, Institute for Experimental Cellular Therapy, University Hospital...

A

Annalisa Ruggeri

8San Raffaele Scientific Institute, Milan, Italy

K

Katharina Fleischhauer

9Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001